Xaliproden lessens oxaliplatin-mediated neuropathy

Lancet Oncol. 2006 Apr;7(4):288. doi: 10.1016/s1470-2045(06)70639-8.
No abstract available

Publication types

  • News

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Colonic Neoplasms / drug therapy
  • Humans
  • Naphthalenes / pharmacology*
  • Organoplatinum Compounds / adverse effects*
  • Organoplatinum Compounds / therapeutic use
  • Oxaliplatin
  • Peripheral Nervous System Diseases / chemically induced*
  • Peripheral Nervous System Diseases / prevention & control*
  • Pyridines / pharmacology*

Substances

  • Antineoplastic Agents
  • Naphthalenes
  • Organoplatinum Compounds
  • Pyridines
  • Oxaliplatin
  • xaliproden